Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 12, 2017 – The FDA announced a Class II recall of one lot of Kalbitor (ecallantide) injection due to the presence of glass particulate matter.
Download PDF
Return to publications
